Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Value-based medicine and vitreoretinal diseases.

Melissa M Brown1, Gary C Brown, Sanjay Sharma

  • 1Center for Value-Based Medicine, 1107 Bethlehem Pike, Flourtown, PA 19031, USA. mbrown@valuebasedmedicine.com

Current Opinion in Ophthalmology
|May 1, 2004
PubMed
Summary

Value-based medicine enhances understanding of vitreoretinal interventions. These treatments, particularly laser procedures for conditions like diabetic retinopathy, are cost-effective and improve patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Ophthalmology. Retina·2023
Same author

Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.

Ophthalmology and therapy·2023
Same author

Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Quality of life associated with no light perception vision.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233-235).

Ophthalmology·2022
Same author

Rural-Urban Comparisons in the Rates of Self-Harm, U.S., 2018.

American journal of preventive medicine·2022

Area of Science:

  • Ophthalmology
  • Health Economics

Background:

  • Value-based medicine integrates clinical evidence with patient-reported outcomes.
  • Cost-utility analysis is a key tool in health economics for assessing intervention value.

Purpose of the Study:

  • To examine the role and impact of value-based medicine on vitreoretinal interventions.
  • To evaluate the cost-effectiveness of various vitreoretinal procedures.

Main Methods:

  • Review of evidence-based data from clinical trials.
  • Application of cost-utility analysis to create a value-based medicine database.
  • Assessment of patient-perceived quality of life improvements.

Main Results:

  • Vitreoretinal interventions generally demonstrate significant cost-effectiveness.

Related Experiment Videos

  • Laser surgical procedures for diabetic retinopathy, retinopathy of prematurity, and exudative macular degeneration are particularly cost-effective.
  • Value-based medicine highlights the substantial patient value derived from these interventions.

    • Conclusions:

    • Vitreoretinal interventions offer high value to patients and are typically cost-effective.
    • Laser therapies represent a cost-effective approach for specific retinal conditions.
    • The integration of value-based medicine principles can guide clinical and economic decision-making in ophthalmology.